UK markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9550+0.0350 (+1.83%)
As of 03:16PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-117,672
-117,672
-95,639
-54,853
-19,955
Depreciation & amortisation
969
969
845
479
2
Stock-based compensation
10,623
10,623
10,606
4,623
633
Change in working capital
6,527
6,527
11,938
6,005
-6,445
Accounts payable
7,367
7,367
2,101
5,150
-
Other working capital
-101,057
-101,057
-73,610
-44,671
-26,433
Other non-cash items
214
214
203
155
1,401
Net cash provided by operating activities
-100,753
-100,753
-72,469
-43,098
-24,113
Cash flows from investing activities
Investments in property, plant and equipment
-304
-304
-1,141
-1,573
-2,320
Purchases of investments
-27,671
-27,671
-95,288
-299,197
-226,837
Sales/maturities of investments
123,064
123,064
154,093
296,691
19,053
Other investing activities
-
-
-
-
36
Net cash used for investing activities
95,089
95,089
57,664
-4,079
-210,068
Cash flows from financing activities
Common stock issued
-
-
0
96,762
208,517
Net cash used provided by (used for) financing activities
493
493
654
97,089
292,750
Net change in cash
-5,171
-5,171
-14,151
49,912
58,569
Cash at beginning of period
96,386
96,386
110,537
60,625
2,056
Cash at end of period
91,215
91,215
96,386
110,537
60,625
Free cash flow
Operating cash flow
-100,753
-100,753
-72,469
-43,098
-24,113
Capital expenditure
-304
-304
-1,141
-1,573
-2,320
Free cash flow
-101,057
-101,057
-73,610
-44,671
-26,433